Mariano Tolentino, MD
Urology · Bloomington, ILNPI 1356315626
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $568, 2.0 times the $284 reported in 2021. That places this record below the midpoint for urology clinicians in IL, where the typical reported total is $2,058.
Across 79 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$347
- Sumitomo Pharma America, Inc.$177
- Olympus America Inc.$169
- Urogen Pharma, Inc.$143
- Ferring Pharmaceuticals Inc.$133
- Endo USA, Inc.$103
- plus $537 from 19 others
What the payments were for
- Food & beverage$1,610100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $347 |
| Sumitomo Pharma America, Inc. | 9 | $177 |
| Olympus America Inc. | 15 | $169 |
| Urogen Pharma, Inc. | 2 | $143 |
| Ferring Pharmaceuticals Inc. | 6 | $133 |
| Endo USA, Inc. | 5 | $103 |
| Boston Scientific | 4 | $71 |
| Astellas Pharma US Inc | 3 | $65 |
| Axonics, Inc. | 2 | $58 |
| Pfizer | 3 | $48 |
| Coloplast | 2 | $33 |
| Bayer | 1 | $25 |
| Medtronic | 1 | $22 |
| Immunitybio, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| ABC Home Medical Supply, Inc. | 1 | $19 |
| 180 Medical, Inc. | 1 | $19 |
| Tolmar, Inc. | 1 | $19 |
| Insulet Corporation | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Merck | 1 | $15 |
| Myriad Genetic Laboratories, Inc. | 1 | $15 |
| Dentsply IH Inc. | 1 | $15 |
| Urovant Sciences Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JELMYTO$125
How this compares
$1,610 in reported general payments places this provider in the 45th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 30 | $16,218 |
| GemtesaVibegron | 14 | $15,430 |
| Tamsulosin Hcl | 358 | $5,446 |
| Oxybutynin Chloride ErOxybutynin Chloride | 71 | $2,301 |
| Finasteride | 134 | $1,916 |
| Testosterone | 18 | $1,740 |
| Estradiol | 20 | $1,182 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 33 | $643 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 47 | $145 |
| Ciprofloxacin Hcl | 21 | $79 |
| Cephalexin | 15 | $49 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $18 |
| Tramadol Hcl | 11 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $65 | $16,21830 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $177 | $15,43014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 550 urology providers in Illinois.
Other urology in Bloomington
- Mark BrandtPark Ridge$1.3M
- Aaron BergerChicago Ridge$583K
- Gary SteinbergChicago$529K
- Simone CrivellaroChicago$526K
- Brian HelfandChicago$517K
- Ashley RossChicago$404K
- Kevin McVarySpringfield$372K
- Richard HarrisMelrose Park$363K
- Amy KrambeckChicago$356K
- Kevin ZornChicago$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.